£118.80

UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation

Actions and Detail Panel

£118.80

Event Information

Share this event

Date and Time

Location

Location

Online Event

Refund Policy

Refund Policy

Contact the organiser to request a refund.

Eventbrite's fee is nonrefundable.

Event description
Our first major cannabinoid research conference in collaboration with National Institute for Health and Care Excellence (NICE)

About this Event

This event will be held on Thursday 15th April and will draw together world leaders in basic and clinical cannabinoid research alongside the most senior policy makers in the UK. They will present a series of lectures covering the most cutting-edge medicinal cannabis research into the use of cannabis-based medicinal products (CBMPs) in three sessions:

  • Evidence and Real World Data
  • Cannabinoids in Practice
  • Cannabinoids in Epilepsy

In an industry first, speakers and session chairs will include representatives from The National Institute for Health and Care Excellence (NICE), National Institute for Health Research (NIHR), The British Pharmacological Society (BPS), Columbia Care, Imperial College London, Sapphire Medical Clinics and UCL-Great Ormond Street Institute of Child Health

The keynote lectures will be delivered by :

  • Dr Paul Chrisp, Director, Centre for Guidelines, NICE,
  • Prof Roger Pertwee, Emeritus Professor, University of Aberdeen, Honorary Fellow of the British Pharmacological Society (BPS) and
  • George Freeman, MP and newly appointed Prime Minister's Task Force on Innovation, Growth and Regulatory Reform (TIGRR)

		UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation image

Networking Coffee Morning

0800-0855 || An opportunity for attendees to build their network and engage with summit attendees and speakers.

Followed by welcome opening statements from Dr Elisabeth Philipps and Dr Daniel Couch.

Session 1 - Evidence and Real World Data

0900-0925 || KEYNOTE ADDRESS

CBMP’s: What does NICE say & why?

SPEAKER: Dr Paul Chrisp,

Director of the Centre for Guidelines, NICE

0930-0955 || LECTURE

1000 patients using CBMP’s - how deep learning informs systematised RWE

SPEAKER: Prof Alistair Vickery

Executive Medical Director, Emyria

1000-1025|| LECTURE

First analysis of the UK Medical Cannabis Registry

SPEAKER: Dr Mikael Sodergren

Senior Clinical Lecturer at Imperial College London

Managing Director of Sapphire Medical Clinics

1030-1055 || LECTURE

How We Best Use Evidence to Judge the Benefits and Harms of Medicines

SPEAKER: Sir Prof Sir John Tooke

Executive Chairman of Academic Health Solutions

1100-1130 || PANEL DISCUSSION

Evidence & Real World Data

Dr Paul Chrisp, Prof Alistair Vickery, Dr Mikael Sodergren, Prof Sir John Tooke

UK Life Sciences Perspective

1200-1225 || KEYNOTE ADDRESS

Cannabinoid Medicine: The New Regulatory and Innovation Environment

SPEAKER: George Freeman MP

Prime Minister's Task Force on Innovation, Growth and Regulatory Reform (TIGRR)

Session 2: Cannabinoids in Practice

1230-1255 || LECTURE

Prevailing Facts and Issues surrounding Pain and Medical Cannabis

SPEAKER: Dr Matthew Brown

Consultant in Pain Medicine & Anaesthetics

1300-1325 || LECTURE

All Pain is not the Same: The use of CBMPs instead of Narcotics

SPEAKER: Dr Rosemary Mazanet

Chief Scientific Officer, Columbia Care

1330-1355 || LECTURE

Plant Vs Synthetic Cannabis

SPEAKER: Dr Parveen Bhatarah

Regulatory and Compliance Lead, Centre for Medicinal Cannabis

1400-1425 || LECTURE

Potential therapeutic uses of certain plant and synthetic cannabinoids revealed by their pharmacological properties’

SPEAKER: Prof Roger Pertwee

Honorary Fellow of the British Pharmacological Society

1430-1455 || Roundtable Sessions

------------------------------------

NIHR Research Review - Theo Christie, Clinical Research Network, NIHR

------------------------------------

Networking Coffee

------------------------------------

Condition Charities Education Roundtable - Dr Daniel Couch with:

Epilepsy Society, Tourettes Action, National Rheumatoid Arthritis Society, & Ehlers-Danlos Support UK

------------------------------------

Session 3: Cannabinoids & Epilepsy

1500-1525 || LECTURE

Cannabinoids in Childhood Epilepsies – Evidence from Clinical Trials

SPEAKER: Prof Helen Cross

UCL-Great Ormond Street Institute of Child Health

1530-1555 || LECTURE

Perspectives on epilepsy: Update on the Evidence in Cannabis for Epilepsy

SPEAKER: Dr. Evan Cole Lewis

Pediatric Neurologist and Epileptologist

1600-1625 || PANEL DISCUSSION

Discussing Epilepsy with Cannabinoids

Prof Helen Cross, Dr Evan Cole Lewis, plus guests

16:30-16:55 || ​END OF DAY LECTURE

Seeing Through the Smoke: The Future of Medical Cannabis

SPEAKER: Peter Grinspoon, M.D.

Instructor in Medicine at Harvard Medical School

16:55-1700 || Closing Statements from Dr Elisabeth Philipps and Dr Daniel Couch

Thank you all for attending.


		UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation image

		UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation image

		UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation image

		UK Medicinal Cannabis Summit 2021: Evidence, Policy & Regulation image
Share with friends

Date and Time

Location

Online Event

Refund Policy

Contact the organiser to request a refund.

Eventbrite's fee is nonrefundable.

Save This Event

Event Saved